Skip to main content
Signal8

Hall Ashley

SEC insider (Form 3/4/5 filer). CIK 0001801842. Chief Development Officer at Structure Therapeutics Inc. (GPCR). 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 19, 2026. Located in SOUTH SAN FRANCISCO, CA.

Companies Hall Ashley has filed insider reports for

  • Structure Therapeutics Inc. (GPCR): Officer, Chief Development Officer
Hall Ashley profile photo

Hall Ashley

CIK: 0001801842

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (71.4%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Structure Therapeutics Inc. logo
GPCR

Structure Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Mar 19, 2026
    Award
    Direct
    47.7K shares-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Mar 3, 2026
    Tax Payment
    Direct
    4.8K shares at avg. $20.99$102K
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Nov 20, 2025
    Award

    American Depositary Shares

    Direct
    237 shares-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Sep 18, 2025
    Tax Payment
    Direct
    6K shares at avg. $7.74$47K
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    May 20, 2025
    Award

    American Depositary Shares

    Direct
    225 shares-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Mar 15, 2025
    Award
    Direct
    51K shares-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Sep 18, 2024
    Award
    Direct
    67.3K shares-

1-7 of 7